May 2024 | ||
---|---|---|
Total Revenue | ||
Cost of Revenue | ||
Gross Profit | ||
Gross Profit Margin (%) | ||
R&D Expense | ||
SG&A Expense | ||
Total Operating Expenses | ||
Operating Income or Loss | ||
Operating Margin (%) | ||
Interest Expense | ||
Total Other Income/Expenses | ||
Income Before Tax | ||
Income Tax Expense | ||
Income from Continuing Ops. | ||
Net Income | ||
Net Profit Margin (%) | ||
Net Income Available to Common Shareholders | ||
Basic EPS | ||
Diluted EPS | ||
Basic Average Shares | ||
Diluted Average Shares |
Aug 2024 | May 2024 | Feb 2024 | Nov 2023 | ||
---|---|---|---|---|---|
Total Revenue | |||||
Cost of Revenue | |||||
Gross Profit | |||||
Gross Profit Margin (%) | |||||
R&D Expense | |||||
SG&A Expense | |||||
Total Operating Expenses | |||||
Operating Income or Loss | |||||
Operating Margin (%) | |||||
Interest Expense | |||||
Total Other Income/Expenses | |||||
Income Before Tax | |||||
Income Tax Expense | |||||
Income from Continuing Ops. | |||||
Net Income | |||||
Net Profit Margin (%) | |||||
Net Income Available to Common Shareholders | |||||
Basic EPS | |||||
Diluted EPS | |||||
Basic Average Shares | |||||
Diluted Average Shares |
May 2024 | ||
---|---|---|
Current Assets | ||
Cash & Cash Equivalents | ||
Marketable Securities | ||
Receivables | ||
Inventories | ||
Other Current Assets | ||
Total Current Assets | ||
Non-Current Assets | ||
Marketable Securities | ||
PPE Net | ||
Intangibles inc. Goodwill | ||
Other Non-Current Assets | ||
Total Non-Current Assets | ||
Total Assets | ||
Current Liabilities | ||
Accounts Payable | ||
Deferred Revenues | ||
Debt, Current | ||
Accrued Liabilities | ||
Other Current Liabilities | ||
Total Current Liabilities | ||
Non-Current Liabilities | ||
Deferred Revenues | ||
Debt, Non-Current | ||
Other Non-Current Liabilities | ||
Total Non-Current Liabilities | ||
Total Liabilities | ||
Shareholders' Equity | ||
Common Stock | ||
Additional Paid-In Capital | ||
Retained Earnings | ||
Other Shareholders' Equity | ||
Total Shareholders' Equity | ||
Total Liabilities & Shareholders' Equity |
Aug 2024 | May 2024 | Feb 2024 | Nov 2023 | ||
---|---|---|---|---|---|
Current Assets | |||||
Cash & Cash Equivalents | |||||
Marketable Securities | |||||
Receivables | |||||
Inventories | |||||
Other Current Assets | |||||
Total Current Assets | |||||
Non-Current Assets | |||||
Marketable Securities | |||||
PPE Net | |||||
Intangibles inc. Goodwill | |||||
Other Non-Current Assets | |||||
Total Non-Current Assets | |||||
Total Assets | |||||
Current Liabilities | |||||
Accounts Payable | |||||
Deferred Revenues | |||||
Debt, Current | |||||
Accrued Liabilities | |||||
Other Current Liabilities | |||||
Total Current Liabilities | |||||
Non-Current Liabilities | |||||
Deferred Revenues | |||||
Debt, Non-Current | |||||
Other Non-Current Liabilities | |||||
Total Non-Current Liabilities | |||||
Total Liabilities | |||||
Shareholders' Equity | |||||
Common Stock | |||||
Additional Paid-In Capital | |||||
Retained Earnings | |||||
Other Shareholders' Equity | |||||
Total Shareholders' Equity | |||||
Total Liabilities & Shareholders' Equity |
May 2024 | ||
---|---|---|
Cash Flows from Operating Activities | ||
Net Income | ||
Depreciation & Amortization | ||
Deferred Income Taxes | ||
Stock Based Compensation | ||
Accounts Receivable | ||
Inventory | ||
Accounts Payable | ||
Deferred Revenue | ||
Other Non-Cash | ||
Operating Cash Flow | ||
Cash Flows from Investing Activities | ||
PPE Investments | ||
Net Acquisitions | ||
Purchase of Investments | ||
Sale of Investments | ||
Other Investing Activity | ||
Investing Cash Flow | ||
Cash Flows from Financing Activities | ||
Debt Issued | ||
Proceeds from Debt Repayment | ||
Debt Repayment | ||
Proceeds from Sale of Equity | ||
Equity Repurchased | ||
Dividend Paid | ||
Other Financing Activity | ||
Financing Cash Flow | ||
Cash Position | ||
Beginning Cash Position | ||
End Cash Position | ||
Change in Cash | ||
Free Cash Flow | ||
Operating Cash Flow | ||
Capital Expenditure | ||
Free Cash Flow |
Aug 2024 | May 2024 | Feb 2024 | Nov 2023 | ||
---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||
Net Income | |||||
Depreciation & Amortization | |||||
Deferred Income Taxes | |||||
Stock Based Compensation | |||||
Accounts Receivable | |||||
Inventory | |||||
Accounts Payable | |||||
Deferred Revenue | |||||
Other Non-Cash | |||||
Operating Cash Flow | |||||
Cash Flows from Investing Activities | |||||
PPE Investments | |||||
Net Acquisitions | |||||
Purchase of Investments | |||||
Sale of Investments | |||||
Other Investing Activity | |||||
Investing Cash Flow | |||||
Cash Flows from Financing Activities | |||||
Debt Issued | |||||
Proceeds from Debt Repayment | |||||
Debt Repayment | |||||
Proceeds from Sale of Equity | |||||
Equity Repurchased | |||||
Dividend Paid | |||||
Other Financing Activity | |||||
Financing Cash Flow | |||||
Cash Position | |||||
Beginning Cash Position | |||||
End Cash Position | |||||
Change in Cash | |||||
Free Cash Flow | |||||
Operating Cash Flow | |||||
Capital Expenditure | |||||
Free Cash Flow |